Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jonas Buchloh"'
Autor:
Malte Simon, Sadaf S. Mughal, Peter Horak, Sebastian Uhrig, Jonas Buchloh, Bogac Aybey, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Benedikt Brors, Charles D. Imbusch
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-17 (2021)
Abstract Background Soft-tissue sarcomas (STS) are a heterogeneous group of mesenchymal tumors for which response to immunotherapies is not well established. Therefore, it is important to risk-stratify and identify STS patients who will most likely b
Externí odkaz:
https://doaj.org/article/95d5e3905f64467eb28b20271478949f
Autor:
Malte Simon, Sadaf S. Mughal, Peter Horak, Sebastian Uhrig, Jonas Buchloh, Bogac Aybey, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Benedikt Brors, Charles D. Imbusch
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/d7c7b1e647bc491ebcae01e7bf9696e0
Autor:
Sebastian Uhrig, Benedikt Brors, Charles D. Imbusch, Hanno Glimm, Peter Horak, Bogac Aybey, Malte Simon, Sadaf S. Mughal, Albrecht Stenzinger, Jonas Buchloh, Stefan Fröhling
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-17 (2021)
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-17 (2021)
Background Soft-tissue sarcomas (STS) are a heterogeneous group of mesenchymal tumors for which response to immunotherapies is not well established. Therefore, it is important to risk-stratify and identify STS patients who will most likely benefit fr